Publication Results

Generate Report

Add publications by marking their checkboxes, or

Feasibility of a Centralized Clinical Trials Coverage Analysis: A Joint Initiative of the American Society of Clinical Oncology and the National Cancer Institute.

Szczepanek CM,  Hurley P,  Good MJ,  Denicoff A,  Willenberg K,  Dawson C,  Kurbegov D
J Oncol Pract 2017 Jun;13(6):395-400
PubMed ID: 28481681
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)

Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: individualized breast cancer prevention.

Ingle JN,  Liu M,  Wickerham DL,  Schaid DJ,  Wang L,  Mushiroda T,  Kubo M,  Costantino JP,  Vogel VG,  Paik S,  Goetz MP,  Ames MM,  Jenkins GD,  Batzler A,  Carlson EE,  Flockhart DA,  Wolmark N,  Nakamura Y,  Weinshilboum RM
Cancer Discov 2013 Jul;3(7):812-25
PubMed ID: 23764426
PMC ID: PMC3710533
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR) ;  Breast Cancer Prevention Trial (BCPT)

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data.

Cuzick J,  Sestak I,  Bonanni B,  Costantino JP,  Cummings S,  DeCensi A,  Dowsett M,  Forbes JF,  Ford L,  LaCroix AZ,  Mershon J,  Mitlak BH,  Powles T,  Veronesi U,  Vogel V,  Wickerham DL,  SERM Chemoprevention of Breast Cancer Overview Group
Lancet 2013 May 25;381(9880):1827-34
PubMed ID: 23639488
PMC ID: PMC3671272
Groups or Programs: Lung and Upper Aerodigestive CancerCommunity Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT) ;  Study of Tamoxifen and Raloxifene (STAR)

National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene trial: advancing the science of recruitment and breast cancer risk assessment in minority communities.

McCaskill-Stevens W,  Wilson JW,  Cook ED,  Edwards CL,  Gibson RV,  McElwain DL,  Figueroa-Moseley CD,  Paskett ED,  Roberson NL,  Wickerham DL,  Wolmark N
Clin Trials 2013 Apr;10(2):280-91
PubMed ID: 23335675
PMC ID: PMC4059676
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Positive and negative affect, depression, and cognitive processes in the Cognition in the Study of Tamoxifen and Raloxifene (Co-STAR) Trial.

Danhauer SC,  Legault C,  Bandos H,  Kidwell K,  Costantino J,  Vaughan L,  Avis NE,  Rapp S,  Coker LH,  Naughton M,  Naylor C,  Terracciano A,  Shumaker S
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2013;20(5):532-52
PubMed ID: 23237718
PMC ID: PMC3815441
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Baseline mammographic breast density and the risk of invasive breast cancer in postmenopausal women participating in the NSABP study of tamoxifen and raloxifene (STAR).

Cecchini RS,  Costantino JP,  Cauley JA,  Cronin WM,  Wickerham DL,  Bandos H,  Weissfeld JL,  Wolmark N
Cancer Prev Res (Phila) 2012 Nov;5(11):1321-9
PubMed ID: 23060039
PMC ID: PMC4131535
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Erratum to 25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1.

Amir E,  Cecchini RS,  Ganz PA,  Costantino JP,  Beddows S,  Hood N,  Goodwin PJ
Breast Cancer Res Treat 2012 Oct;135(3):923
PubMed ID: not available
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifene.

Powles TJ,  Diem SJ,  Fabian CJ,  Neven P,  Wickerham DL,  Cox DA,  Muram D,  Agnusdei D,  Dowsett SA,  Amewou-Atisso M,  Cummings SR
Breast Cancer Res Treat 2012 Jul;134(1):299-306
PubMed ID: 22484799
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1.

Amir E,  Cecchini RS,  Ganz PA,  Costantino JP,  Beddows S,  Hood N,  Goodwin PJ
Breast Cancer Res Treat 2012 Jun;133(3):1077-88
PubMed ID: 22415479
PMC ID: PMC3396331
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

Using the gene ontology to scan multilevel gene sets for associations in genome wide association studies.

Schaid DJ,  Sinnwell JP,  Jenkins GD,  McDonnell SK,  Ingle JN,  Kubo M,  Goss PE,  Costantino JP,  Wickerham DL,  Weinshilboum RM
Genet Epidemiol 2012 Jan;36(1):3-16
PubMed ID: 22161999
PMC ID: PMC3310255
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT) ;  Study of Tamoxifen and Raloxifene (STAR)

Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR).

Runowicz CD,  Costantino JP,  Wickerham DL,  Cecchini RS,  Cronin WM,  Ford LG,  Vogel VG,  Wolmark N
Am J Obstet Gynecol 2011 Dec;205(6):535.e1-5
PubMed ID: 21872200
PMC ID: PMC5160016
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP) ;  Office of the Director
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: results from the NSABP P1 and P2 clinical trials.

Goetz MP,  Schaid DJ,  Wickerham DL,  Safgren S,  Mushiroda T,  Kubo M,  Batzler A,  Costantino JP,  Vogel VG,  Paik S,  Carlson EE,  Flockhart DA,  Wolmark N,  Nakamura Y,  Weinshilboum RM,  Ingle JN,  Ames MM
Clin Cancer Res 2011 Nov 1;17(21):6944-51
PubMed ID: 21880792
PMC ID: PMC3207003
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT) ;  Study of Tamoxifen and Raloxifene (STAR)

Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor-positive breast cancer.

Kim C,  Tang G,  Pogue-Geile KL,  Costantino JP,  Baehner FL,  Baker J,  Cronin MT,  Watson D,  Shak S,  Bohn OL,  Fumagalli D,  Taniyama Y,  Lee A,  Reilly ML,  Vogel VG,  McCaskill-Stevens W,  Ford LG,  Geyer CE Jr,  Wickerham DL,  Wolmark N,  Paik S
J Clin Oncol 2011 Nov 1;29(31):4160-7
PubMed ID: 21947828
PMC ID: PMC3208536
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP) ;  Office of the Director
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

Cigarette smoking, obesity, physical activity, and alcohol use as predictors of chemoprevention adherence in the National Surgical Adjuvant Breast and Bowel Project P-1 Breast Cancer Prevention Trial.

Land SR,  Cronin WM,  Wickerham DL,  Costantino JP,  Christian NJ,  Klein WM,  Ganz PA
Cancer Prev Res (Phila) 2011 Sep;4(9):1393-400
PubMed ID: 21862698
PMC ID: PMC3180877
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older.

Freedman AN,  Yu B,  Gail MH,  Costantino JP,  Graubard BI,  Vogel VG,  Anderson GL,  McCaskill-Stevens W
J Clin Oncol 2011 Jun 10;29(17):2327-33
PubMed ID: 21537036
PMC ID: PMC3107748
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Estimated risk of invasive breast cancer in postmenopausal women with and without family history of the disease.

Sontag A,  Wickerham L,  Ni X,  Mitchell BD,  Helt C,  Muram D
Menopause 2011 May;18(5):515-20
PubMed ID: 21178791
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

A Bayesian Shrinkage Model for Incomplete Longitudinal Binary Data with Application to the Breast Cancer Prevention Trial.

Wang C,  Daniels MJ,  Scharfstein DO,  Land S
J Am Stat Assoc 2010 Dec;105(492):1333-1346
PubMed ID: 21516191
PMC ID: PMC3079242
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

Identification of accrual barriers onto breast cancer prevention clinical trials: a case-control study.

Houlihan RH,  Kennedy MH,  Kulesher RR,  Lemon SC,  Wickerham DL,  Hsieh CC,  Altieri DC
Cancer 2010 Aug 1;116(15):3569-76
PubMed ID: 20564133
PMC ID: PMC3077438
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Breast cancer chemoprevention: progress and controversy.

Wickerham DL
Surg Oncol Clin N Am 2010 Jul;19(3):463-73
PubMed ID: 20620921
PMC ID: PMC3034655
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT) ;  Study of Tamoxifen and Raloxifene (STAR)

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer.

Vogel VG,  Costantino JP,  Wickerham DL,  Cronin WM,  Cecchini RS,  Atkins JN,  Bevers TB,  Fehrenbacher L,  Pajon ER,  Wade JL 3rd,  Robidoux A,  Margolese RG,  James J,  Runowicz CD,  Ganz PA,  Reis SE,  McCaskill-Stevens W,  Ford LG,  Jordan VC,  Wolmark N,  National Surgical Adjuvant Breast and Bowel Project
Cancer Prev Res (Phila) 2010 Jun;3(6):696-706
PubMed ID: 20404000
PMC ID: PMC2935331
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP) ;  Community Clinical Oncology Program (CCOP)
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Relative effects of tamoxifen, raloxifene, and conjugated equine estrogens on cognition.

Espeland MA,  Shumaker SA,  Limacher M,  Rapp SR,  Bevers TB,  Barad DH,  Coker LH,  Gaussoin SA,  Stefanick ML,  Lane DS,  Maki PM,  Resnick SM
J Womens Health (Larchmt) 2010 Mar;19(3):371-9
PubMed ID: 20136553
PMC ID: PMC2867626
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP) ;  Community Clinical Oncology Program (CCOP)
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Novel pathway analysis of genomic polymorphism-cancer risk interaction in the Breast Cancer Prevention Trial.

Dunn BK,  Greene MH,  Kelley JM,  Costantino JP,  Clifford RJ,  Hu Y,  Tang G,  Kazerouni N,  Rosenberg PS,  Meerzaman DM,  Buetow KH
Int J Mol Epidemiol Genet 2010;1(4):332-49
PubMed ID: 21152245
PMC ID: PMC2998292
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)Chemopreventive Agent Development
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

Carcinoma in situ outcomes in National Surgical Adjuvant Breast and Bowel Project Breast Cancer Chemoprevention Trials.

Vogel VG,  Costantino JP,  Wickerham DL,  McCaskill-Stevens W,  Clarfeld RB,  Grant MD,  Wolmark N
J Natl Cancer Inst Monogr 2010;2010(41):181-6
PubMed ID: 20956826
PMC ID: PMC5161067
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT) ;  Study of Tamoxifen and Raloxifene (STAR)

Effects of tamoxifen and raloxifene on memory and other cognitive abilities: cognition in the study of tamoxifen and raloxifene.

Legault C,  Maki PM,  Resnick SM,  Coker L,  Hogan P,  Bevers TB,  Shumaker SA
J Clin Oncol 2009 Nov 1;27(31):5144-52
PubMed ID: 19770382
PMC ID: PMC2773473
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP) ;  Community Clinical Oncology Program (CCOP)
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

The NSABP Study of Tamoxifen and Raloxifene (STAR) trial.

Vogel VG
Expert Rev Anticancer Ther 2009 Jan;9(1):51-60
PubMed ID: 19105706
PMC ID: PMC2785111
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Tamoxifen chemoprevention treatment and time to first diagnosis of estrogen receptor-negative breast cancer.

Shen Y,  Costantino JP,  Qin J
J Natl Cancer Inst 2008 Oct 15;100(20):1448-53
PubMed ID: 18840821
PMC ID: PMC2720727
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP) ;  Community Clinical Oncology Program (CCOP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer.

Ganz PA,  Land SR
Menopause 2008 Jul-Aug;15(4 Suppl):797-803
PubMed ID: 18596601
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife women.

Cella D,  Land SR,  Chang CH,  Day R,  Costantino JP,  Wolmark N,  Ganz PA
Breast Cancer Res Treat 2008 Jun;109(3):515-26
PubMed ID: 17851765
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

Projecting individualized absolute invasive breast cancer risk in African American women.

Gail MH,  Costantino JP,  Pee D,  Bondy M,  Newman L,  Selvan M,  Anderson GL,  Malone KE,  Marchbanks PA,  McCaskill-Stevens W,  Norman SA,  Simon MS,  Spirtas R,  Ursin G,  Bernstein L
J Natl Cancer Inst 2007 Dec 5;99(23):1782-92
PubMed ID: 18042936
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP) ;  Community Clinical Oncology Program (CCOP)
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Inference of Tamoxifen's Effects on Prevention of Breast Cancer from a Randomized Controlled Trial.

Shen Y,  Qin J,  Costantino JP
J Am Stat Assoc 2007 Dec 1;102(480):1235-1244
PubMed ID: 19662105
PMC ID: PMC2721282
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.

Abramson N,  Costantino JP,  Garber JE,  Berliner N,  Wickerham DL,  Wolmark N
J Natl Cancer Inst 2006 Jul 5;98(13):904-10
PubMed ID: 16818854
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP) ;  Community Clinical Oncology Program (CCOP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Land SR,  Wickerham DL,  Costantino JP,  Ritter MW,  Vogel VG,  Lee M,  Pajon ER,  Wade JL 3rd,  Dakhil S,  Lockhart JB Jr,  Wolmark N,  Ganz PA
JAMA 2006 Jun 21;295(23):2742-51
PubMed ID: 16754728
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Vogel VG,  Costantino JP,  Wickerham DL,  Cronin WM,  Cecchini RS,  Atkins JN,  Bevers TB,  Fehrenbacher L,  Pajon ER Jr,  Wade JL 3rd,  Robidoux A,  Margolese RG,  James J,  Lippman SM,  Runowicz CD,  Ganz PA,  Reis SE,  McCaskill-Stevens W,  Ford LG,  Jordan VC,  Wolmark N,  National Surgical Adjuvant Breast and Bowel Project (NSABP)
JAMA 2006 Jun 21;295(23):2727-41
PubMed ID: 16754727
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP) ;  Office of the Director ;  Community Clinical Oncology Program (CCOP)
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).

Beattie MS,  Costantino JP,  Cummings SR,  Wickerham DL,  Vogel VG,  Dowsett M,  Folkerd EJ,  Willett WC,  Wolmark N,  Hankinson SE
J Natl Cancer Inst 2006 Jan 18;98(2):110-5
PubMed ID: 16418513
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.

Fisher B,  Costantino JP,  Wickerham DL,  Cecchini RS,  Cronin WM,  Robidoux A,  Bevers TB,  Kavanah MT,  Atkins JN,  Margolese RG,  Runowicz CD,  James JM,  Ford LG,  Wolmark N
J Natl Cancer Inst 2005 Nov 16;97(22):1652-62
PubMed ID: 16288118
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP) ;  Community Clinical Oncology Program (CCOP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial.

Chalas E,  Costantino JP,  Wickerham DL,  Wolmark N,  Lewis GC,  Bergman C,  Runowicz CD
Am J Obstet Gynecol 2005 Apr;192(4):1230-9
PubMed ID: 15846210
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

Lower-category benign breast disease and the risk of invasive breast cancer.

Wang J,  Costantino JP,  Tan-Chiu E,  Wickerham DL,  Paik S,  Wolmark N
J Natl Cancer Inst 2004 Apr 21;96(8):616-20
PubMed ID: 15100339
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

Effects of tamoxifen on benign breast disease in women at high risk for breast cancer.

Tan-Chiu E,  Wang J,  Costantino JP,  Paik S,  Butch C,  Wickerham DL,  Fisher B,  Wolmark N
J Natl Cancer Inst 2003 Feb 19;95(4):302-7
PubMed ID: 12591986
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

Effect of tamoxifen on venous thrombosis risk factors in women without cancer: the Breast Cancer Prevention Trial.

Cushman M,  Costantino JP,  Bovill EG,  Wickerham DL,  Buckley L,  Roberts JD,  Krag DN
Br J Haematol 2003 Jan;120(1):109-16
PubMed ID: 12492585
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

National surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ.

Vogel VG,  Costantino JP,  Wickerham DL,  Cronin WM
Clin Cancer Res 2003 Jan;9(1 Pt 2):495S-501S
PubMed ID: 12538506
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT) ;  Study of Tamoxifen and Raloxifene (STAR)

Quality of life and tamoxifen in a breast cancer prevention trial: a summary of findings from the NSABP P-1 study. National Surgical Adjuvant Breast and Bowel Project.

Day R,  National Surgical Adjuvant Breast and Bowel Projet P-1 study (NSABP-1)
Ann N Y Acad Sci 2001 Dec;949:143-50
PubMed ID: 11795346
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

King MC,  Wieand S,  Hale K,  Lee M,  Walsh T,  Owens K,  Tait J,  Ford L,  Dunn BK,  Costantino J,  Wickerham L,  Wolmark N,  Fisher B,  National Surgical Adjuvant Breast and Bowel Project
JAMA 2001 Nov 14;286(18):2251-6
PubMed ID: 11710890
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP) ;  Community Clinical Oncology Program (CCOP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

Tamoxifen and depression: more evidence from the National Surgical Adjuvant Breast and Bowel Project's Breast Cancer Prevention (P-1) Randomized Study.

Day R,  Ganz PA,  Costantino JP
J Natl Cancer Inst 2001 Nov 7;93(21):1615-23
PubMed ID: 11698565
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

Tamoxifen and cardiac risk factors in healthy women: Suggestion of an anti-inflammatory effect.

Cushman M,  Costantino JP,  Tracy RP,  Song K,  Buckley L,  Roberts JD,  Krag DN
Arterioscler Thromb Vasc Biol 2001 Feb;21(2):255-61
PubMed ID: 11156862
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

Cardiovascular effects of tamoxifen in women with and without heart disease: breast cancer prevention trial. National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial Investigators.

Reis SE,  Costantino JP,  Wickerham DL,  Tan-Chiu E,  Wang J,  Kavanah M
J Natl Cancer Inst 2001 Jan 3;93(1):16-21
PubMed ID: 11136837
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.

Gail MH,  Costantino JP,  Bryant J,  Croyle R,  Freedman L,  Helzlsouer K,  Vogel V
J Natl Cancer Inst 1999 Nov 3;91(21):1829-46
PubMed ID: 10547390
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

Validation studies for models projecting the risk of invasive and total breast cancer incidence.

Costantino JP,  Gail MH,  Pee D,  Anderson S,  Redmond CK,  Benichou J,  Wieand HS
J Natl Cancer Inst 1999 Sep 15;91(18):1541-8
PubMed ID: 10491430
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

Day R,  Ganz PA,  Costantino JP,  Cronin WM,  Wickerham DL,  Fisher B
J Clin Oncol 1999 Sep;17(9):2659-69
PubMed ID: 10561339
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

Fisher B,  Costantino JP,  Wickerham DL,  Redmond CK,  Kavanah M,  Cronin WM,  Vogel V,  Robidoux A,  Dimitrov N,  Atkins J,  Daly M,  Wieand S,  Tan-Chiu E,  Ford L,  Wolmark N
J Natl Cancer Inst 1998 Sep 16;90(18):1371-88
PubMed ID: 9747868
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP) ;  Community Clinical Oncology Program (CCOP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

Compliance with quality of life data collection in the National Surgical Adjuvant Breast and Bowel Project (NSABP) Breast Cancer Prevention Trial.

Ganz PA,  Day R,  Costantino J
Stat Med 1998 Mar 15-Apr 15;17(5-7):613-22
PubMed ID: 9549810
PMC ID: not available
Groups or Programs: Community Oncology and Prevention TrialsNCI Community Oncology Research Program (NCORP)
Clinical Trials: Breast Cancer Prevention Trial (BCPT)